Furthermore, we identify that YTHDF2 facilitates TMZ resistance in GBM by the activation of the PI3K/Akt and NF‐κB signalling pathways through inhibiting expression of EPHB3 and TNFAIP3. The gene discussed is EPHB3; the disease is glioblastoma.